Onconetix (ONCO) Cash from Investing Activities (2022 - 2024)
Onconetix (ONCO) posted quarterly Cash from Investing Activities of -$3874.0 for Q4 2024, down 100.32% year-over-year from $1.2 million in Q1 2024, and down 67.49% quarter-over-quarter from -$2313.0 in Q3 2024.
Onconetix (ONCO) Cash from Investing Activities (2022 - 2024) Analysis & Trends
Onconetix (ONCO) has reported Cash from Investing Activities for 3 consecutive years, with -$3874.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Cash from Investing Activities fell 100.32% year-over-year to -$3874.0; the TTM figure through Dec 2024 stood at -$28471.0 (up 99.67% YoY), while the FY2024 annual figure was -$28471.0, up 99.67% from the prior year.
- Cash from Investing Activities fell to -$3874.0 in Q4 2024 per ONCO's latest filing, from -$2313.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $1.2 million in Q4 2023 and bottomed at -$10.0 million in Q2 2023.
- Historically, Cash from Investing Activities has averaged -$725847.6 across 3 years, with a median of -$4887.5 in 2022.
- On a YoY basis, Cash from Investing Activities climbed as much as 103377.66% in 2023 and fell as far as 83369.85% in 2023.
- Onconetix's Cash from Investing Activities stood at -$1177.0 in 2022, then jumped by 103377.66% to $1.2 million in 2023, then slumped by 100.32% to -$3874.0 in 2024.
- Business Quant data shows ONCO's Cash from Investing Activities at -$3874.0 in Q4 2024, -$2313.0 in Q3 2024, and -$17706.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -3,874.00 |
| Dec 31, 2024 | -3,874.00 |
| Sep 30, 2024 | -2,313.00 |
| Sep 30, 2024 | -2,313.00 |
| Jun 30, 2024 | -17,706.00 |
| Jun 30, 2024 | -17,706.00 |
| Mar 31, 2024 | -4,578.00 |
| Mar 31, 2024 | -4,578.00 |
| Dec 31, 2023 | 1.22 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Sep 30, 2023 | 173,015.00 |
| Sep 30, 2023 | 173,015.00 |
| Jun 30, 2023 | -10.00 Mn |
| Jun 30, 2023 | -10.00 Mn |
| Mar 31, 2023 | -36,271.00 |
| Mar 31, 2023 | -36,271.00 |
| Dec 31, 2022 | -1,177.00 |
| Dec 31, 2022 | -1,177.00 |
| Sep 30, 2022 | -14,309.00 |
| Sep 30, 2022 | -14,309.00 |